J
Jerome A. Yesavage
Researcher at Stanford University
Publications - 446
Citations - 43320
Jerome A. Yesavage is an academic researcher from Stanford University. The author has contributed to research in topics: Cognition & Dementia. The author has an hindex of 73, co-authored 423 publications receiving 39527 citations. Previous affiliations of Jerome A. Yesavage include United States Department of Veterans Affairs & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Selected psychiatric symptoms associated with rate of cognitive decline in patients with Alzheimer's disease.
TL;DR: The findings suggest a relation between the presence of certain behavioral problems in Alzheimer's disease and decline in particular cognitive areas.
Journal ArticleDOI
A Retrospective Chart Review of Gabapentin for the Treatment of Aggressive and Agitated Behavior in Patients With Dementias
TL;DR: The authors examined the use of gabapentin for the treatment of aggressive and agitated behaviors in nursing home patients with a DSM-IV diagnosis of dementia and found that 17 of 22 patients were much or greatly improved; 4 were minimally improved; and only 1 remained unchanged.
Journal ArticleDOI
Automatic and effortful processing in aging and dementia: event-related brain potentials.
Judith M. Ford,Judith M. Ford,Walton T. Roth,Walton T. Roth,B.G. Isaacks,B.G. Isaacks,Jared R. Tinklenberg,Jared R. Tinklenberg,Jerome A. Yesavage,Jerome A. Yesavage,Adolf Pfefferbaum,Adolf Pfefferbaum +11 more
TL;DR: Investigation of event-related brain potentials recorded from moderately impaired subjects with probable Alzheimer's Disease, normal elderly, and normal young controls found effects of age and disease depended on how P300 was elicited; when automatically elicited, P300 amplitude was affected by age but not disease.
Book ChapterDOI
Everyday cognition in adulthood and late life: Mnemonics as modified for use by the elderly
Journal ArticleDOI
Delineating a Retesting Zone Using Receiver Operating Characteristic Analysis on Serial QuantiFERON Tuberculosis Test Results in US Healthcare Workers.
Wendy Thanassi,Art Noda,Beatriz Hernandez,Jeffery Newell,Paul Terpeluk,David Marder,Jerome A. Yesavage,Jerome A. Yesavage +7 more
TL;DR: A statistically significant separation point for the QuantiFERON Gold In-Tube (QFT) interferon gamma release assay that could define an optimal “retesting zone” for use in serially tested low-risk populations who have test “reversions” from initially positive to subsequently negative results is found.